Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura K Schnackenberg

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Pharmacogenomics|October 24, 2006
Metabolomics Special Focus: an introductionLaura K Schnackenberg
Expert Review of Molecular Diagnostics|May 11, 2007
Global metabolic profiling and its role in systems biology to advance personalized medicine in the 21st centuryLaura K Schnackenberg
Drug Discovery Today. Technologies|July 2, 2014
Metabolomic biomarkers: their role in the critical pathLaura K Schnackenberg, Richard D Beger
Toxicology Mechanisms and Methods|December 22, 2009
The role of metabolic biomarkers in drug toxicity studiesLaura K Schnackenberg, Richard D Beger
Journal of Chemical Information and Modeling|April 6, 2005
Whole-molecule calculation of log p based on molar volume, hydrogen bonds, and simulated 13C NMR spectraLaura K Schnackenberg, Richard D Beger
Pharmacogenomics|October 24, 2006
Monitoring the health to disease continuum with global metabolic profiling and systems biologyLaura K Schnackenberg, Richard D Beger
Drug Metabolism Letters|August 26, 2009
Studies of acetaminophen and metabolites in urine and their correlations with toxicity using metabolomicsJinchun Sun, Laura K Schnackenberg, Richard D Beger
Methods in Molecular Biology (Clifton, N.J.)|September 15, 2012
Metabolomics techniques in nanotoxicology studiesLaura K Schnackenberg, Jinchun Sun, Richard D Beger
Personalized Medicine|May 16, 2018
Metabolomics as a tool for personalizing medicine: 2012 updateJinchun Sun, Richard D Beger, Laura K Schnackenberg
Toxicology and Applied Pharmacology|November 26, 2009
Metabolomics approaches for discovering biomarkers of drug-induced hepatotoxicity and nephrotoxicityRichard D Beger, Jinchun Sun, Laura K Schnackenberg
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Pharmacogenomics|October 24, 2006
Metabolomics Special Focus: an introductionLaura K Schnackenberg
Expert Review of Molecular Diagnostics|May 11, 2007
Global metabolic profiling and its role in systems biology to advance personalized medicine in the 21st centuryLaura K Schnackenberg
Drug Discovery Today. Technologies|July 2, 2014
Metabolomic biomarkers: their role in the critical pathLaura K Schnackenberg, Richard D Beger
Toxicology Mechanisms and Methods|December 22, 2009
The role of metabolic biomarkers in drug toxicity studiesLaura K Schnackenberg, Richard D Beger
Journal of Chemical Information and Modeling|April 6, 2005
Whole-molecule calculation of log p based on molar volume, hydrogen bonds, and simulated 13C NMR spectraLaura K Schnackenberg, Richard D Beger
Pharmacogenomics|October 24, 2006
Monitoring the health to disease continuum with global metabolic profiling and systems biologyLaura K Schnackenberg, Richard D Beger
Drug Metabolism Letters|August 26, 2009
Studies of acetaminophen and metabolites in urine and their correlations with toxicity using metabolomicsJinchun Sun, Laura K Schnackenberg, Richard D Beger
Methods in Molecular Biology (Clifton, N.J.)|September 15, 2012
Metabolomics techniques in nanotoxicology studiesLaura K Schnackenberg, Jinchun Sun, Richard D Beger
Personalized Medicine|May 16, 2018
Metabolomics as a tool for personalizing medicine: 2012 updateJinchun Sun, Richard D Beger, Laura K Schnackenberg
Toxicology and Applied Pharmacology|November 26, 2009
Metabolomics approaches for discovering biomarkers of drug-induced hepatotoxicity and nephrotoxicityRichard D Beger, Jinchun Sun, Laura K Schnackenberg
Pageof 5